NO960120L - ECF dobbelkontrast - Google Patents

ECF dobbelkontrast

Info

Publication number
NO960120L
NO960120L NO960120A NO960120A NO960120L NO 960120 L NO960120 L NO 960120L NO 960120 A NO960120 A NO 960120A NO 960120 A NO960120 A NO 960120A NO 960120 L NO960120 L NO 960120L
Authority
NO
Norway
Prior art keywords
ecf
double contrast
contrast
human
relates
Prior art date
Application number
NO960120A
Other languages
English (en)
Norwegian (no)
Other versions
NO960120D0 (no
Inventor
Anders Ericsson
Anne Kjersti Fahlvik
Tore Bach-Gansmo
Anders Hemmingsson
Mats Wikstrom
Audun Oeksendal
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO960120D0 publication Critical patent/NO960120D0/no
Publication of NO960120L publication Critical patent/NO960120L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Signal Processing (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Semiconductor Lasers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO960120A 1993-07-12 1996-01-11 ECF dobbelkontrast NO960120L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939314499A GB9314499D0 (en) 1993-07-12 1993-07-12 Method
PCT/GB1994/001500 WO1995002831A1 (en) 1993-07-12 1994-07-11 Methods and compositions for image contrast enhancing

Publications (2)

Publication Number Publication Date
NO960120D0 NO960120D0 (no) 1996-01-11
NO960120L true NO960120L (no) 1996-03-11

Family

ID=10738767

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960120A NO960120L (no) 1993-07-12 1996-01-11 ECF dobbelkontrast

Country Status (14)

Country Link
US (2) US5869023A (de)
EP (1) EP0708927B1 (de)
JP (1) JPH09502426A (de)
CN (1) CN1127040A (de)
AT (1) ATE166464T1 (de)
AU (1) AU7129594A (de)
CA (1) CA2165086A1 (de)
DE (1) DE69410466T2 (de)
ES (1) ES2116600T3 (de)
GB (1) GB9314499D0 (de)
NO (1) NO960120L (de)
NZ (1) NZ268397A (de)
WO (1) WO1995002831A1 (de)
ZA (1) ZA945038B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619758D0 (en) * 1996-09-23 1996-11-06 Nycomed Imaging As Method
WO1998011922A2 (en) * 1996-02-16 1998-03-26 Nycomed Imaging As Method
DE19719033C1 (de) * 1997-04-29 1999-01-28 Schering Ag Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel
GB9809776D0 (en) * 1998-05-07 1998-07-08 Nycomed Imaging As Method
SE9803718D0 (sv) * 1998-05-26 1998-10-28 Klaus Potthoff Diagnostiseringsmedel
JP2002522514A (ja) * 1998-08-10 2002-07-23 ブラッコ・リサーチ・ソシエテ・アノニム ポジティブｍｒｉコントラスト剤とネガティブｍｒｉコントラスト剤との組合せ
EP1210124A2 (de) * 1999-07-29 2002-06-05 Epix Medical, Inc. Zielrichtung von multimere bilderzeugung mitteln durch multilocus bindung
US6804546B1 (en) * 2001-04-20 2004-10-12 Koninklijke Philips Electronics, N.V. Multiple contrast echo-planar imaging for contrast-enhanced imaging
US6723052B2 (en) 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
TWI221406B (en) 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
NO20020780D0 (no) * 2002-02-15 2002-02-15 Amersham Health As Bildeanalyse
US8357351B2 (en) 2004-04-21 2013-01-22 Ananth Annapragada Nano-scale contrast agents and methods of use
US7713517B2 (en) 2004-04-21 2010-05-11 Marval Biosciences, Inc. Compositions and methods for enhancing contrast in imaging
CN1950713A (zh) * 2004-05-03 2007-04-18 皇家飞利浦电子股份有限公司 磁共振成像系统和方法
EP1771205B1 (de) 2004-06-18 2016-10-26 Ambrx, Inc. Neuartige antigen-bindende polypeptide und ihre verwendungen
US20060020152A1 (en) * 2004-07-22 2006-01-26 Theobald Eugene H Method for the low temperature selective oxidation of hydrogen contained in a hydrocarbon stream
NO20043746L (no) * 2004-09-07 2006-03-08 Heidi Brurok MRI-metode for a vurdere myokardisk funksjon, levedyktighet og perfusjon i ischemisk hjertesykdom
US7854705B2 (en) * 2004-12-16 2010-12-21 Olga Pawluczyk Ex vivo verification of biopsy tissue samples
CN101189531A (zh) * 2005-06-01 2008-05-28 皇家飞利浦电子股份有限公司 通过mr分子成像确定造影剂的分布信息
WO2008128033A1 (en) * 2007-04-11 2008-10-23 Oregon Health & Science University Method and apparatus for noninvasive quantitative detection of fibrosis in the heart
CA2699394C (en) 2007-09-17 2020-03-24 The Regents Of The University Of California Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
CA2708028A1 (en) * 2007-12-05 2009-06-11 Marval Biosciences, Inc. Nano-scale contrast agents and methods of use
WO2009152445A1 (en) * 2008-06-13 2009-12-17 Marval Biosciences, Inc. Imaging of atherosclerotic plaques using liposomal imaging agents
WO2010037233A1 (en) * 2008-10-02 2010-04-08 The University Of Western Ontario System and method for processing images
US20140170068A1 (en) 2011-03-11 2014-06-19 Board Of Regents Of The University Of Nebraska Biomarker for coronary artery disease
EP3383920B1 (de) 2015-11-30 2024-01-10 The Regents of the University of California Freisetzung von tumorspezifischer nutzlast und immunaktivierung mit einem menschlichen antikörper gegen hochspezifisches tumorzellenoberflächenantigen
EP3538551A4 (de) 2016-11-10 2020-11-11 Fortis Therapeutics, Inc. Cd46-specifische effektorzellen und verwendungen davon
US11504546B2 (en) 2019-02-28 2022-11-22 Cowles Ventures, Llc Needle guidance device for brachytherapy and method of use
US11524176B2 (en) 2019-03-14 2022-12-13 Cowles Ventures, Llc Locator for placement of fiducial support device method
JP2023534765A (ja) 2020-08-07 2023-08-10 フォーティス セラピューティクス，インク． 免疫複合体を標的とするｃｄ４６およびその使用方法
US11630219B2 (en) * 2021-07-29 2023-04-18 Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C Pressure-regulating large-area windowless airflow proportional counter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4972837A (en) * 1983-04-26 1990-11-27 Regents Of The University Of California Contrast agents for nuclear magnetic resonance imaging
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
GB8808305D0 (en) * 1988-04-08 1988-05-11 Nycomed As Compositions
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
IT1246380B (it) * 1990-04-12 1994-11-18 Bracco Spa Sali insolubili di lantanidi per la visualizzazione in risonanza magnetica nucleare del tratto gastro-intestinale
US5143716A (en) * 1991-02-01 1992-09-01 Unger Evan C Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region

Also Published As

Publication number Publication date
GB9314499D0 (en) 1993-08-25
CN1127040A (zh) 1996-07-17
NZ268397A (en) 1997-11-24
US6045775A (en) 2000-04-04
NO960120D0 (no) 1996-01-11
DE69410466D1 (de) 1998-06-25
ZA945038B (en) 1995-03-27
WO1995002831A1 (en) 1995-01-26
US5869023A (en) 1999-02-09
AU7129594A (en) 1995-02-13
DE69410466T2 (de) 1999-02-18
EP0708927A1 (de) 1996-05-01
EP0708927B1 (de) 1998-05-20
JPH09502426A (ja) 1997-03-11
ATE166464T1 (de) 1998-06-15
CA2165086A1 (en) 1995-01-26
ES2116600T3 (es) 1998-07-16

Similar Documents

Publication Publication Date Title
NO960120D0 (no) ECF dobbelkontrast
TR199901133T2 (xx) �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe eden bile�ikler ve y�ntemler.
DK0806968T3 (da) Diagnostiske billeddannelseskontrastmidler med foröget blodretention
FI896234A7 (fi) Parannuksia magneettisessa resonanssikuvauksessa ja siihen liittyen
FI962557L (fi) PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa
DK528385D0 (da) Kontrastmidler
EP0699051A4 (de) Makromolekulares kontrastmittel zur bilderzeugung mittels magnetischer kernresonanz
ZA951295B (en) 6-substituted mycophenolic acid and derivatives
EP0639270A4 (de) Phosphorylierte kontrastmittel für die magnetische kernresonanz des gastro-intestinalen trakts.
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
GEP20053423B (en) Method of Inhibiting Amyloid Protein Aggregation and Method for Imaging of Amyloid Deposits
NO984555D0 (no) T1- Lever
RU94011321A (ru) Способ профилактики и лечения заболеваний кожи
DK0745071T3 (da) 4-Amino-6-substitueret mycophenolsyre og derivater med immunsuppressiv virkning
ATE151996T1 (de) Kit zur einführung eines fremdkörpers, der geeignet zur identifikation eines tieres ist
BR9506838A (pt) Derivados de ácido micofenólico substituídos na posição 5
ZA961919B (en) Use of magnetites to determine the perfusion of human tissue with the aid of mr diagnosis
FI952953A7 (fi) Aineita metabolisten luustosairauksien hoitamiseen
CA2271735A1 (en) Magnetic resonance blood pool agents
IT1276040B1 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf
ATE90363T1 (de) Lectine, die beta-d-galactosid binden.
FR2726771B3 (fr) Corps magnetique avec moyen de fixation
ES1025816Y (es) Colchon ortopedico magnetizado masajeador
GB8810128D0 (en) Phospholipids & their use as magnetic resonance imaging contrast agents
NO962831D0 (no) Kontrastmidler for röntgen og magnettomografisk avbildning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application